Laruparetigene Zovaparvovec
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Laruparetigene Zovaparvovec, covering 2026-02-19 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa [Phase 2]